Increased liver fibrosis assessed by magnetic resonance elastography among patients with nonalcoholic fatty liver disease and type 2 diabetes correlated with a higher risk for cardiovascular risk, according to published data.
“Accurately assessing [cardiovascular disease] risk in NAFLD patients is critical to improving clinical outcomes,” Neeraj Mangla, MD, from the NAFLD Research Center in La Jolla, California, and colleagues wrote. “Utilization of liver stiffness measurements to non-invasively assess for liver fibrosis is broadening and magnetic resonance elastography (MRE) is the most accurate modality in NAFLD.” To determine if MRE-assessed liver fibrosis stage is associated with CVD risk, Mangla and colleagues evaluated 96 adult patients with type 2 diabetes, 63 of whom had NAFLD....
To read more, go to Healio: https://www.healio.com/hepatology/steatohepatitis-metabolic-liver-disease/news/online/%7B24e082a5-3bfb-4867-bfc5-e352094648a5%7D/mre-links-liver-stiffness-cvd-risk-in-patients-with-type-2-diabetes
To view the full study, go to: https://www.cghjournal.org/article/S1542-3565(19)30513-0/fulltext
